ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 09, 2026.
The Healthcare company reported Q0 revenue of .
ANAVEX LIFE SCIENCES CORP.'s stock currently trades at $4.35 with a market capitalization of $367.2M.


